This episode was recorded on April 15, 2020.To claim credit visit: https://ce.mayo.edu/covid19podcastGuest: Alexander S. Niven, M.D. (@niven_alex)Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) When a patient presents with dyspnea how can we reliably predict who will progress to respiratory failure? How can phenotypes of disease progression be utilized for optimizing selection of treatment modalities? Dr. Alex Niven discusses Fleischner Society recommendations for imaging as a COVID-19 screening tool, cytokine storm, ventilator-associated lung injury, post-ICU care syndrome, and humanity in critical care.Deeper Dive:Mayo Clinic COVID-19 Resources for Providers https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providersFleischner Society GuidelinesRubin G, Haramati L, Kanne J, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Radiology. 2020 April 07; p.201365. https://doi.org/10.1148/radiol.2020201365The Berlin DefinitionThe ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.